CNBC's Angelica Peebles and AstraZeneca CEO Pascal Soriot join 'Squawk Box' to discuss the company's breast cancer drug trial ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, ...

Pascal Soriot, Director at Agilent Technologies (NYSE:A), reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares ...

FRANKFURT (Reuters) - Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023 ...

AstraZeneca’sAZN3.10%increase; green up pointing triangle longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming ...

AstraZeneca’s Pascal Soriot is no stranger to shareholder scrutiny—especially when it comes to the longtime CEO’s pay. But the latest campaign against his re-election is nothing short of ...

Is any employee worth paying £18.7m? That’s the monster sum AstraZeneca has awarded its chief executive, Pascal Soriot, who’s in line for a £1.5m salary with the rest in mostly share-based ...

Pascal Soriot, 65, fought off a takeover attempt of AstraZeneca Plc in the early stages of his 12-year run as chief executive officer before developing the company into a cancer drugs powerhouse ...

Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...